- Scrip
- >>Business
- >>Financing
Finance Watch: Big Money In Post-Data Follow-On Offerings
With Cash Limited, Others Cut Programs, Jobs
Public Company Edition: Insmed grossed $650m, Structure raised $476m and Merus brought in $400.2m after positive clinical trial results. But while CARGO raised $110m in a private placement and Day One sold a priority review voucher for $108m, Ikena, Takeda and others cut jobs.
Insmed Incorporated, Structure Therapeutics, Inc. and Merus N.V. raised more than $1.5bn combined in recent follow-on public offerings (FOPOs), taking advantage of a spike in investor interest and their surging stock prices after announcing positive clinical trial results.
Bridgewater, NJ-based Insmed’s stock price more than doubled to $48.06 on 28 May when it reported positive results from the...